GlobeNewswire: Nutra Pharma Corp. Contains the last 10 of 25 releaseshttp://www.globenewswire.com/External?Length=42024-03-29T11:27:15ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2024/03/22/2851152/0/en/Nutra-Pharma-Corp-Reaches-Settlement-with-SEC.html?f=22&fvtc=4&fvtv=43598Nutra Pharma Corp. Reaches Settlement with SEC2024-03-22T20:39:45Z<![CDATA[Nutra Pharma Corp. has reached a bifurcated settlement with the SEC along with its CEO and a Consultant to the company Nutra Pharma Corp. has reached a bifurcated settlement with the SEC along with its CEO and a Consultant to the company]]>https://www.globenewswire.com/news-release/2022/03/23/2408664/0/en/Nutra-Pharma-Announces-First-Manufacturing-Agreement.html?f=22&fvtc=4&fvtv=43598Nutra Pharma Announces First Manufacturing Agreement2022-03-23T13:15:00Z<![CDATA[Nutra Pharma is announcing Avini Health as its first contract manufacturing partner Nutra Pharma is announcing Avini Health as its first contract manufacturing partner]]>https://www.globenewswire.com/news-release/2022/03/17/2405345/0/en/Nutra-Pharma-Expands-Manufacturing-Capabilities.html?f=22&fvtc=4&fvtv=43598Nutra Pharma Expands Manufacturing Capabilities2022-03-17T13:15:00Z<![CDATA[Nutra Pharma is providing updates on their work in improving manufacturing scale and capabilities for new product launches for their OTC drugs and potential dietary supplements Nutra Pharma is providing updates on their work in improving manufacturing scale and capabilities for new product launches for their OTC drugs and potential dietary supplements]]>https://www.globenewswire.com/news-release/2022/01/18/2368795/0/en/Nutra-Pharma-Letter-to-Shareholders.html?f=22&fvtc=4&fvtv=43598Nutra Pharma Letter to Shareholders2022-01-18T17:44:20Z<![CDATA[Nutra Pharma has published their annual letter to shareholders to the Company’s website Nutra Pharma has published their annual letter to shareholders to the Company’s website]]>https://www.globenewswire.com/news-release/2021/07/26/2268759/0/en/Nutra-Pharma-Provides-Business-and-Compliance-Updates.html?f=22&fvtc=4&fvtv=43598Nutra Pharma Provides Business and Compliance Updates2021-07-26T14:30:00Z<![CDATA[Nutra Pharma is providing updates regarding their business plans, accounting and compliance Nutra Pharma is providing updates regarding their business plans, accounting and compliance]]>https://www.globenewswire.com/news-release/2021/07/23/2268050/0/en/Nutra-Pharma-Files-Updated-Provisional-Patent-for-Nerve-Agent-Counter-Measures.html?f=22&fvtc=4&fvtv=43598Nutra Pharma Files Updated Provisional Patent for Nerve Agent Counter Measures2021-07-23T13:14:52Z<![CDATA[Nutra Pharma has filed an updated provisional patent for the protection of their intellectual property surrounding the use of RPI-78M and analogs of the drug as potential counter-measures against organophosphate nerve agents Nutra Pharma has filed an updated provisional patent for the protection of their intellectual property surrounding the use of RPI-78M and analogs of the drug as potential counter-measures against organophosphate nerve agents]]>https://www.globenewswire.com/news-release/2021/07/15/2263551/0/en/Nutra-Pharma-Engages-Government-Affairs-Consulting-Firm.html?f=22&fvtc=4&fvtv=43598 Nutra Pharma Engages Government Affairs Consulting Firm2021-07-15T12:30:00Z<![CDATA[Nutra Pharma is working with Washington DC-based government affairs consultants and lobbyists to support their Nyloxin® line of pain relief products as well as act as liaisons to governmental agencies Nutra Pharma is working with Washington DC-based government affairs consultants and lobbyists to support their Nyloxin® line of pain relief products as well as act as liaisons to governmental agencies]]>https://www.globenewswire.com/news-release/2019/05/30/1859379/0/en/Nutra-Pharma-Announces-that-Nyloxin-is-Now-Available-on-the-iRemedy-Marketplace.html?f=22&fvtc=4&fvtv=43598Nutra Pharma Announces that Nyloxin is Now Available on the iRemedy Marketplace2019-05-30T12:30:00Z<![CDATA[The iRemedy Healthcare Companies, an industry leader in ecommerce medical supplies and medical business consulting, announced the addition of the Nyloxin® line of pain relief products to their marketplace The iRemedy Healthcare Companies, an industry leader in ecommerce medical supplies and medical business consulting, announced the addition of the Nyloxin® line of pain relief products to their marketplace]]>https://www.globenewswire.com/news-release/2019/04/10/1801985/0/en/Nutra-Pharma-Responds-to-FDA-Warning-Letter.html?f=22&fvtc=4&fvtv=43598Nutra Pharma Responds to FDA Warning Letter2019-04-10T12:30:00Z<![CDATA[Nutra Pharma has provided a response to the FDA warning letter sent to the company on March 11, 2019 regarding Nutra Pharma’s homeopathic drug, Nyloxin® Nutra Pharma has provided a response to the FDA warning letter sent to the company on March 11, 2019 regarding Nutra Pharma’s homeopathic drug, Nyloxin®]]>https://www.globenewswire.com/news-release/2018/09/28/1587345/0/en/Nutra-Pharma-Comments-on-SEC-Complaint.html?f=22&fvtc=4&fvtv=43598Nutra Pharma Comments on SEC Complaint2018-09-28T21:58:20Z<![CDATA[Nutra Pharma is providing comments on the SEC Complaint filed against Nutra Pharma, its CEO and a Consultant to the company.]]>